Cost‐effectiveness analysis of an active search to retrieve <scp>HCV</scp> patients lost to follow‐up ( <scp>RELINK‐C</scp> strategy) and the impact of <scp>COVID</scp> ‐19-Reference-Cited by-同舟云学术

Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up ( RELINK‐C strategy) and the impact of COVID ‐19

Published:2022-05-23 Issue:7 Volume:29 Page:579-583
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Vargas‐Accarino Elena¹²^ORCID,Martínez‐Campreciós Joan¹²^ORCID,Domínguez‐Hernández Raquel³^ORCID,Rando‐Segura Ariadna⁴⁵,Riveiro‐Barciela Mar¹²⁶^ORCID,Rodríguez‐Frías Francisco⁶⁷⁸,Barreira Ana¹²,Palom Adriana¹²,Casado Miguel Ángel³,Esteban Rafael¹⁶,Buti María¹²⁶^ORCID

Affiliation:

1. Liver Unit, Internal Medicine Department Hospital Universitari Vall d'Hebron Barcelona Spain

2. Department of Medicine Universitat Autònoma de Barcelona Barcelona Spain

3. Pharmacoeconomics & Outcomes Research Iberia (PORIB) Madrid Spain

4. Department of Microbiology Hospital Universitari Vall d'Hebron Barcelona Spain

5. Department of Microbiology Universitat Autònoma de Barcelona Bellaterra Spain

6. CIBERehd Instituto Carlos III Barcelona Spain

7. Biochemistry and Microbiology Department Clinical Laboratories Hospital Universitari Vall d'Hebron Barcelona Spain

8. Liver Pathology Unit, Biochemistry and Microbiology Departments Hospital Universitari Vall d'Hebron Barcelona Spain

Funder

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13686

Reference8 articles.

1. Hepatitis C elimination in the Netherlands (CELINE): study protocol for nationwide retrieval of lost to follow-up patients with chronic hepatitis C

2. Impact of the COVID-19 pandemic on HCV elimination in Spain

3. Impact of COVID-19 on global HCV elimination efforts

4. Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment;BMC Public Health;2024-09-06

2. Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective‐prospective study;Alimentary Pharmacology & Therapeutics;2024-08-27

3. ReLink strategy in diagnosed-but-untreated hepatitis C-positive patients in Germany: report from a single center;Zeitschrift für Gastroenterologie;2024-07-16

4. Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice;American Journal of Obstetrics and Gynecology;2024-07

5. Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study;Liver International;2023-12-18